Cardiovascular

Population Management Tool Reduces Adverse Events of DOACs

December 3rd 2020, 11:30pm

Article

The use of a population health management tool may reduce adverse events that may arise from the inappropriate prescribing of direct-acting oral anticoagulants (DOACs).

Carotid Artery Lipid Core Associated With CVD, Independent of Artery Wall Thickness

November 27th 2020, 9:15pm

Article

It remains unclear whether measures of magnetic resonance imaging plaque characteristics are associated with cardiovascular disease events independent of plaque burden at the population level.

Association Between Clogged Arteries and Body Size Phenotype? Study Finds, “It Varies”

November 25th 2020, 4:30pm

Article

Study Highlights Finerenone Benefits in CV Outcomes for Patients With CKD

November 17th 2020, 1:10am

Article

Finerenone may represent an important step forward to reducing cardiac illness and death in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), the study said.

Fish Oil Debate Continues as Study Finds No Risk Reduction From Omega-3 Combo

November 15th 2020, 3:58pm

Article

The investigator of the STRENGTH study says findings raise questions about the landmark REDUCE-IT trial, but other evidence suggests the drugs involved are different.

AHA Telemetry Guidelines Improve Telemetry Utilization in the Inpatient Setting

November 10th 2020, 2:00pm

Article

Using Plan-Do-Study-Act cycles, the studied intervention reduced hospital inpatient telemetry time by 51.25% while increasing American Heart Association (AHA) guideline–based usage.

Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting

November 10th 2020, 2:00pm

Article

The authors report overutilization of telemetry monitoring in a community setting, increasing the cost of health care and potential harm to patients with unnecessary interventions.

Social Determinants of Health Score: Does It Help Identify Those at Higher Cardiovascular Risk?

October 19th 2020, 1:00pm

Article

Calculating a social score is feasible and it predicts cardiovascular outcomes. In order to do this, institutions have to collect social determinants of health.

Considering Cost Effectiveness in Cardiovascular Risk Reduction

September 16th 2020, 1:00pm

Video

Vascepa Brings 36% Drop in Surgeries to Restore Blood Flow, Results Show

July 25th 2020, 6:00pm

Article

Deepak L. Bhatt, MD, MPH, of Brigham and Women’s Hospital Heart & Vascular Center and Harvard Medical School, presented the latest round of data from REDUCE-IT at the American Society of Preventive Cardiology Virtual Summit 2020 this morning